Manager TitleAgeSince
Chief Executive Officer - 2024-03-12
Director TitleAgeSince
Director/Board Member - 2023-06-06
Director/Board Member - 2023-06-06
Date Insider Type Main position Quantity % Market Cap.
12/11/25 Sell 500,000 -
12/11/25 Other

Chief Executive Officer

0 -
12/11/25 Sell

Director

800,000 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 8.49M
+1.01%+1.01%-13.78%-5.57% 13.27B
+1.98%+0.33%-35.14%-57.05% 4.95B
+1.85%-5.05%-6.75%-2.34% 4.64B
+1.58%-4.23%-1.29%-28.74% 4B
+1.01%+0.61%-21.17%+5.44% 3.57B
+2.21%+3.87%-6.13%-3.71% 3.42B
-0.47%-4.16%-13.69%+11.83% 3.28B
+0.86%-3.04%-19.63%-15.55% 2.4B
+1.82%-1.23%-31.46%-11.34% 1.69B
Average +1.19%-1.10%-16.56%-11.89% 4.58B
Weighted average by Cap. +1.28%-0.82%-15.41%-11.96%
Logo Orion Nutraceuticals Inc.
Orion Nutraceuticals Inc. is a Canada-based company. The Company is primarily focused on re-purposing a United States food and drug administration approved drug to target asthma and chronic obstructive pulmonary disease (COPD).
Employees
-